Ofichem brings all brands under single trading name
April 23, 2026Ofichem
Ofichem has brought all its brands under its trading name to provide its customers a single integrated offering. The company …
Carvolix strengthens its Board of Directors, advisory board and governance structure
April 23, 2026Carvolix
Carvolix (formerly Affluent Medical) has announced it is strengthening its Board of Directors, advisory board and governance structure. As part …
Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC
April 22, 2026University of Huddersfield’s NHIC
Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, recently visited the newly opened Emily Siddon …
Incyclix Bio announces new additions to the Board
April 22, 2026Incyclix Bio
Incyclix Bio has announced that it has raised $5m in additional funds for its Series B financing from new investor …
Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO
April 21, 2026Remedy Plan Therapeutics
Remedy Plan Therapeutics has appointed Jotin Marango as Chief Financial and Business Officer (CFO & CBO). “Joti brings a strong …
Xilio Therapeutics appoints Cheryl R Blanchard to Board
April 20, 2026Xilio Therapeutics
Xilio Therapeutics has announced the appointment of Cheryl R Blanchard to the company’s board of directors. The company also announced …
Kayentis and RWS partner to improve clinical trial data confidence
April 17, 2026Research and Development RWS, kayentis
Kayentis and RWS have announced a partnership aimed at improving confidence in clinical trial data for neuroscience and other complex …
MHRA expands its pioneering AI Airlock programme with £3.6m funding boost
April 16, 2026Research and Development
The Medicines and Healthcare products Regulatory Agency (MHRA) has secured new funding to expand its AI Airlock programme, aimed at …
Ardena opens new US bioanalytical laboratory
April 15, 2026Business Services
Ardena has announced that its new GLP bioanalytical laboratory in Somerset, New Jersey in the US is operational and supporting …
Gesynta Pharma doses first patient in endometriosis phase 2 trial
April 14, 2026Research and Development Gesynta Pharma, endometriosis
Gesynta Pharma has dosed the first patient in its phase 2 clinical proof-of-concept trial of vipoglanstat. The trial, NOVA, is …
Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says
April 13, 2026Astellas Pharma, menopause
Final draft NICE guidance has recommended Veoza (fezolinetant), made by Astellas Pharma, to treat moderate to severe menopausal hot flushes …
Sandoz launches allergy relief nasal spray in Germany and Switzerland
April 9, 2026Ear Nose & throat
Sandoz has launched its azelastine and fluticasone fixed-dose-combination (FDC) nasal spray in Germany and Switzerland. In Germany the FDC over …
Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer
April 9, 2026Oncology
The Japan Pharmaceuticals and Medical Devices Agency (PMDA) has accepted the updated prescribing information for Daiichi Sankyo’s Enhertu (trastuzumab), a …
Trelleborg to take part in Medtec Japan 2026
April 8, 2026Manufacturing and Production
Trelleborg Medical Solutions will showcase its latest engineered polymer solutions for demanding medical, biotech and pharmaceutical applications at Medtec Japan …
Kainova Therapeutics expands phase I/II trial of antibody drug
April 7, 2026Research and Development
Kainova Therapeutics has announced that the first patient in the European expansion of its DOMISOL phase I/II clinical trial evaluating …
Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086
April 7, 2026Research and Development
Eisai is to begin enrolling participants in its phase 2 study, Study 202, in patients with narcolepsy. The company registered …
Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer
April 2, 2026Faron Pharmaceuticals
Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Heikki Jouttijärvi as Chief Technical Officer (CTO). Jouttijärvi brings decades of experience …
Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London
April 1, 2026Conferencing, Events & Incentives Cambridge, Cambridge Wide Open Week, London, Oxford
Cambridge Wide Open Week (CWOW) returns from 11-19 June 2026, sharing the spirit and buzz of the week-long, interactive festival …
Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO
April 1, 2026Doccla
Doccla, an AI-powered Proactive Care company, has appointed Michael Macdonnell as Chief Strategy & Growth Officer, and Deputy CEO. As …
Bramacare launches new AI platform to improve eating disorder care
March 31, 2026Market & Product Development AI, Bramacare, eating disorders
Bramacare has launched an AI-enabled platform designed to aid eating disorder and rehabilitation services, the first of its kind in …
